These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15129316)

  • 1. Use of imiquimod cream 5% in the treatment of localized morphea.
    Man J; Dytoc MT
    J Cutan Med Surg; 2004; 8(3):166-9. PubMed ID: 15129316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First case series on the use of imiquimod for morphoea.
    Dytoc M; Ting PT; Man J; Sawyer D; Fiorillo L
    Br J Dermatol; 2005 Oct; 153(4):815-20. PubMed ID: 16181467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized scleroderma: a clinical study at a single center in Korea.
    Noh JW; Kim J; Kim JW
    Int J Rheum Dis; 2013 Aug; 16(4):437-41. PubMed ID: 23992265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lymphomatoid papulosis with imiquimod 5% cream.
    Hughes PS
    J Am Acad Dermatol; 2006 Mar; 54(3):546-7. PubMed ID: 16488317
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the efficacy and safety of topical imiquimod 5% for plaque-type morphea: a multicenter, prospective, vehicle-controlled trial.
    Dytoc M; Wat H; Cheung-Lee M; Sawyer D; Ackerman T; Fiorillo L
    J Cutan Med Surg; 2015; 19(2):132-9. PubMed ID: 25775634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical imiquimod 5% cream for pediatric plaque morphea: a prospective, multiple-baseline, open-label pilot study.
    Pope E; Doria AS; Theriault M; Mohanta A; Laxer RM
    Dermatology; 2011; 223(4):363-9. PubMed ID: 22327486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of non-genital warts with topical imiquimod 5% cream.
    Muzio G; Massone C; Rebora A
    Eur J Dermatol; 2002; 12(4):347-9. PubMed ID: 12095879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PUVA-cream photochemotherapy for the treatment of localized scleroderma.
    Grundmann-Kollmann M; Ochsendorf F; Zollner TM; Spieth K; Sachsenberg-Studer E; Kaufmann R; Podda M
    J Am Acad Dermatol; 2000 Oct; 43(4):675-8. PubMed ID: 11004625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scar management after breast surgery: preliminary results of a prospective, randomized, and double-blind clinical study with aldara cream 5% (imiquimod).
    Prado A; Andrades P; Benitez S; Umaña M
    Plast Reconstr Surg; 2005 Mar; 115(3):966-72. PubMed ID: 15731724
    [No Abstract]   [Full Text] [Related]  

  • 10. Imiquimod in clinical practice.
    Edwards L
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open label safety study of topical imiquimod 5% cream in the treatment of Molluscum contagiosum in children.
    Barba AR; Kapoor S; Berman B
    Dermatol Online J; 2001 Feb; 7(1):20. PubMed ID: 11328641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of actinic cheilitis with imiquimod 5% and a retractor on the lower lip: clinical and histological outcomes in 5 patients.
    McDonald C; Laverick S; Fleming CJ; White SJ
    Br J Oral Maxillofac Surg; 2010 Sep; 48(6):473-6. PubMed ID: 19836865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream.
    Deeths MJ; Chapman JT; Dellavalle RP; Zeng C; Aeling JL
    J Am Acad Dermatol; 2005 Feb; 52(2):275-80. PubMed ID: 15692473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized morphea: a case report.
    Payapvipapong K; Aunhachoke K
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S215-7. PubMed ID: 21280538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
    Geisse J; Caro I; Lindholm J; Golitz L; Stampone P; Owens M
    J Am Acad Dermatol; 2004 May; 50(5):722-33. PubMed ID: 15097956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological and clinical profile of imiquimod (BESELNA CREAM 5%)].
    Tsuda T; Imada K; Mizuguchi K
    Nihon Yakurigaku Zasshi; 2008 Jul; 132(1):55-63. PubMed ID: 18622104
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical imiquimod as an adjuvant to laser removal of mature tattoos in an animal model.
    Ramirez M; Magee N; Diven D; Colome-Grimmer M; Motamedi M; Oliveira G; Zamora JG; Uchida T; Wagner RF
    Dermatol Surg; 2007 Mar; 33(3):319-25. PubMed ID: 17338690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine dermatitis and febrile seizure from imiquimod.
    Mosher JS; Lio P
    Pediatrics; 2012 Feb; 129(2):e519-22. PubMed ID: 22218836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiqimod in clinical practice.
    Trofatter KF
    Eur J Dermatol; 1998; 8(7 Suppl):17-9; discussion 20-2. PubMed ID: 10387959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma.
    Hulshof MM; Bouwes Bavinck JN; Bergman W; Masclee AA; Heickendorff L; Breedveld FC; Dijkmans BA
    J Am Acad Dermatol; 2000 Dec; 43(6):1017-23. PubMed ID: 11100017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.